{"product_id":"biolegend-100722","title":"Biolegend, 100722, PE\/Cyanine7 anti-mouse CD8a Antibody, 100μg","description":"\u003cp\u003eCD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)\/β(CD8b) heterodimer and α\/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α\/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α\/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α\/α homodimer is expressed on a subset of γ\/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.\u003cbr\u003e\n100μg\u003cbr\u003e\nVerified Reactivity: Mouse\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Rat\u003cbr\u003e\nImmunogen: Mouse thymus or spleen\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with PE\/Cyanine7 under optimal conditions.\u003cbr\u003e\nConcentration: 0.2 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)Green Laser (532 nm)\/Yellow-Green Laser (561 nm)\u003cbr\u003e\nApplication Notes: Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin \u0026lt; 0.01 EU\/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP) Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete) Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP) Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block) Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC) Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC) Shih FF, et al. 2006. J. Immunol. 176:3438. (FC) Kamimura D, et al. 2006. J. Immunol. 177:306. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete) Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed Lee CH, et al. 2009. Clin. Cancer Res. PubMed Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed Kenna TJ, et al. 2008. Blood 111:2091. PubMed Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed Medyouf H, et al. 2010. Blood 115:1175. PubMed Riedl P, et al. 2009. J. Immunol. 183:370. PubMed Apte SH, et al. 2010. J. Immunol. 185:998. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed Cui L, et al. 2015. J Control Release. 206:220. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed\u003cbr\u003e\nProduct Citations: Calabrese DR, et al. 2020. J Clin Invest. . PubMed Jarick KJ, et al. 2018. Front Immunol. 9:1468. PubMed Seo JB, et al. 2019. Nat Metab. 1:86. PubMed Yu X, et al. 2020. Nat Commun. 11:1110. PubMed Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed Axelrod ML, et al. 2022. Nature. 611:818. PubMed Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed Li L, et al. 2023. iScience. 26:106095. PubMed Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed Cheng K, et al. 2023. Small. 19:e2300125. PubMed Li G, et al. 2023. Cell Death Dis. 14:185. PubMed Guo D, et al. 2023. Cell Biosci. 13:51. PubMed Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed Sun R, et al. 2023. PLoS One. 18:e0282722. PubMed Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed Vick SC, et al. 2021. J Immunol. 207:2598. PubMed Li H, et al. 2022. Cancer Cell. 40:36. PubMed Xin B, et al. 2022. Hepatology. 76:630. PubMed Schnell A, et al. 2021. Cell. 184:6281. PubMed Fu A, et al. 2022. Cell. 185:1356. PubMed Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed Guttman O, et al. 2022. J Cell Biol. 221: . PubMed Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed Gao Y, et al. 2022. Cell Res. 32:1086. PubMed Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed Giannou AD, et al. 2023. Immunity. 56:125. PubMed Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed Wang C, et al. 2023. Exp Mol Med. 55:347. PubMed Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed Georgiev GI, et al. 2022. Cell Chem Biol. 29:811. PubMed Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed Wu N, et al. 2020. Cell Rep. 30:1129. PubMed Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed Tello\u0026amp;dash;Lafoz M, et al. 2017. Sci Rep. . 10.1038\/s41598-017-16370-w. PubMed Denk D, et al. 2022. Immunity. 55:2059. PubMed Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed Ferrere G, et al. 2021. JCI Insight. 6:. PubMed Li X, et al. 2022. Nat Commun. 13:2794. PubMed Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed Ma F, et al. 2020. Cell Death Dis. 1.172222222. PubMed Baram T, et al. 2021. Cells. 10:. PubMed Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed Luo R, et al. 2021. Theranostics. 11:117. PubMed Hu J, et al. 2021. Sci Adv. 7:. PubMed Mei S, et al. 2022. Front Immunol. 13:911164. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed Wu FTH, et al. 2019. Br J Cancer. 120:196. PubMed Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed Zhao J, et al. 2019. Nat Commun. 10:899. PubMed Bowers E, et al. 2018. Nat Med. 24:95. PubMed Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed Tan X, et al. 2021. Front Oncol. 11:768222. PubMed Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed Saito S, et al. 2020. Nutrients. 12:. PubMed Neubert K, et al. 2014. J Immunol. 192:5830. PubMed Sakthivel P, et al. 2014. PLoS One. 9:100970. PubMed Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed Pan H, et al. 2020. Mol Psychiatry. . PubMed Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed Cai B, et al. 2021. Mol Cancer. 20:165. PubMed Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed Shade K, et al. 2015. J Exp Med. 212:457. PubMed Liu J, et al. 2012. PLoS One. 7:e44044. PubMed Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed Guo HF, et al. 2021. Commun Biol. 4:482. PubMed Wei M, et al. 2014. Protein Eng Des Sel. 27:289. PubMed Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed Amor C, et al. 2020. Nature. 583:127. PubMed Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed Li J, et al. 2020. Cancer Discov. . PubMed Wei SC, et al. 2020. Cancer Discov. . PubMed He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed Alsaleh G, et al. 2020. Elife. 9: . PubMed Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed Yang K, et al. 2022. J Clin Invest. 132:. PubMed Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed Dane EL, et al. 2022. Nat Mater. 21:710. PubMed Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed Köchl R, et al. 2020. Elife. 9:00. PubMed Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed Yang S, et al. 2019. Nat Commun. 10:2782. PubMed Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed Dar HY, et al. 2018. Bone Rep. 8:46. PubMed Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed Yue X, et al. 2019. Nat Commun. 10:2011. PubMed Li J, et al. 2018. Immunity. 49:178. PubMed Domingo–Gonzalez R, et al. 2020. eLife. 9:e56890.. PubMed Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed Progatzky F, et al. 2021. Nature. 599:125. PubMed Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed Mulas F, et al. 2020. Cell Mol Immunol. . PubMed Wen Y, et al. 2020. Hypertension. 869:75. PubMed Qi S et al. 2016. eLife. 5 pii: e14756. PubMed Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed , et al. 2021. Eur J Immunol. 51:2708. PubMed Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed Reese B, et al. 2020. J Immunol. 205:3218. PubMed Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed Ariyoshi Y, et al. 2016. Gene Ther. 10.1038\/gt.2016.7. PubMed Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed Zhang H, et al. 2019. Mol Cell. 76:110. PubMed Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed Tan X, et al. 2021. Sci Adv. 7: . PubMed Sapra L, et al. 2021. Sci Rep. 11:1807. PubMed Alameh MG, et al. 2021. Immunity. 54:2877. PubMed Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed Yang Y, et al. 2022. Elife. 11:. PubMed Kim S, et al. 2021. Elife. 10:. PubMed Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed Yu X, et al. 2019. Nat Commun. 10:574. PubMed Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed Ding P, et al. 2022. Bone Res. 10:42. PubMed Lang V, et al. 2021. Elife. 10:. PubMed Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed Timilshina M, et al. 2017. PLoS One. 10.1371\/journal.pone.0168942. PubMed Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed Xu Q, et al. 2021. Theranostics. 11:1937. PubMed Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed Kalafati L, et al. 2020. Cell. 183:771. PubMed Muri J, et al. 2020. eLife. 9:e53627.. PubMed He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed Yuan X, et al. 2017. Elife. 6:e29540. PubMed Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed Emily A Thompson et al. 2019. Cell reports. 26(11):2859-2867 . PubMed Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed Bhatt D, et al. 2021. J Exp Med. 218:. PubMed Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed Abdelsamed HA, et al. 2020. Nat Immunol. 1.276388889. PubMed Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed Silva DA, et al. 2019. Nature. 565:186. PubMed Lee YS, et al. 2019. Sci Adv. 5:eaaw4176. PubMed Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed Xiao Y, et al. 2021. Cell. 184:6037. PubMed Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed Yoshida H, et al. 2019. Cell. 176:897. PubMed Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed Lopes N, et al. 2022. Elife. 11:. PubMed Tang S, et al. 2022. Virol J. 19:32. PubMed Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed Bonavita E, et al. 2020. Immunity. 1215:53. PubMed Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed Sheng J, et al. 2021. eLife. 10:00. PubMed Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed Ding Z, et al. 2017. Sci Rep. 10.1038\/s41598-017-12488-z. PubMed Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed Lau P, et al. 2022. Cell Mol Immunol. :. PubMed Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed Wang X, et al. 2022. Elife. 11:. PubMed Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed Goc J, et al. 2021. Cell. 184:5015. PubMed Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed Lai NY, et al. 2020. Cell. 180:33:00. PubMed Wang X, et al. 2021. Sci Transl Med. 13:. PubMed Goubet AG, et al. 2021. Cell Death Differ. 28:2276. PubMed Petty AJ, et al. 2021. JCI Insight. 6:. PubMed Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed Chen S, et al. 2018. Nat Commun. 9:5298. PubMed Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed Fearon AE, et al. 2021. iScience. 24:103143. PubMed Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed\u003cbr\u003e\nRRID: AB_312760 (BioLegend Cat. No. 100721) AB_312761 (BioLegend Cat. No. 100722)\u003cbr\u003e\nStructure: Ig superfamily, CD8α chain, 34 kD\u003cbr\u003e\nDistribution: Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells\u003cbr\u003e\nFunction: Co-receptor for TCR\u003cbr\u003e\nLigand\/Receptor: MHC class I molecule\u003cbr\u003e\nAntigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Zamoyska R. 1994. Immunity 1:243. 3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.\u003cbr\u003e\nGene ID: 12525\u003cbr\u003e\nUniProt: View information about CD8alpha on UniProt.org\u003cbr\u003e\nClone: 53-6.7\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: T8, Lyt2, Ly-2\u003cbr\u003e\nIsotype: Rat IgG2a, κ\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46862433550505,"sku":"100722","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/biolegend-100722","provider":"Iright","version":"1.0","type":"link"}